Novel approaches for vaccine development

Cited by (347)

Items 101–200 of 347

  1. Animal vaccine revolution: Nanoparticle adjuvants open the future of vaccinology
    Shangen Xu, Chenxi Sun, Tianyu Qian, Yao Chen, Xinhui Dong, Afei Wang, Qihong Zhang, Yawei Ji, Zheng Jin, Chibo Liu et al. · 2025 · Journal of Controlled Release
  2. A peptide-based subunit candidate vaccine against SARS-CoV-2 delivered by biodegradable mesoporous silica nanoparticles induced high humoral and cellular immunity in mice
    Lei Qiao, Minmin Chen, Suyan Li, Jinxia Hu, Chaoju Gong, Zhuoqi Zhang, Xichuan Cao · 2021 · Biomaterials Science
  3. Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens
    Becca A. Flitter, Molly R. Braun, Sean N. Tucker · 2022 · Vaccines
  4. Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2
    Nura Adam Mohamed, Haissam Abou-Saleh, Hana A. Mohamed, Mohammad Ahmad Al-Ghouti, Sérgio Crovella, Luisa Zupin · 2022 · Viruses
  5. Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials
    Tristan William Clark, John S. Tregoning, Helen R. Fisher, Tiziano Poletti, Femy Amin, Jonathan S. Nguyen‐Van‐Tam · 2024 · Clinical Microbiology Reviews
  6. Antigen-capturing oncolytic adenoviruses along with IDO blockade for improved tumor immunotherapy
    Xu Chen, Keman Cheng, Xinwei Wang, Jingjing Liu, Jie Liang, Guangna Liu, Yichao Lu, Ming Tang, Dingfei Qian, Liting Chen et al. · 2023 · Nano Today
  7. Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target
    Alan S. Cross · 2023 · Microbiology and Molecular Biology Reviews
  8. Advancement in the development of mRNA ‐based vaccines for respiratory viruses
    Tays Troncoso‐Bravo, Mario A. Ramírez, Ricardo A. Loaiza, Carolina Román-Cárdenas, Georgios Papazisis, Daniel A. Garrido, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis · 2024 · Immunology
  9. Optimal delivery strategies for nanoparticle-mediated mRNA delivery
    Xiaoyan Li, Xiaocui Guo, Mingdi Hu, Rong Cai, Chunying Chen · 2023 · Journal of Materials Chemistry B
  10. Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and Prospects
    Xiong Li, Yajuan Zhu, Ying Xue, Tingting Chen, Xiaoke Sun, Hongyang Shi · 2025 · Cancers
  11. Novel Administration Routes, Delivery Vectors, and Application of Vaccines Based on Biotechnologies: A Review
    Chung-I Rai, Tsu-Hsiang Kuo, Yuan‐Chuan Chen · 2024 · Vaccines
  12. Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
    Darin K. Edwards, Andrea Carfı́ · 2022 · Current Opinion in Immunology
  13. Innovative Immunoinformatics Tools for Enhancing MHC (Major Histocompatibility Complex) Class I Epitope Prediction in Immunoproteomics
    Gomase VS, Rupali Sharma, Suchita Prabhakar Dhamane · 2025 · Protein and Peptide Letters
  14. Advances and Strategies in Enhancing mRNA Cancer Vaccines
    Miao Zhang, Shengqi Chen, Hai-Jun Hu, Yenhui Ong, Qianqian Ni · 2025 · Advanced Materials
  15. Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines
    Alessio Alesci, Marco Gitto, Magdalena Kotańska, Patrizia Lo Cascio, Anthea Miller, Noemi Nicosia, Angelo Fumia, Simona Pergolizzi · 2022 · Human Immunology
  16. Adiponectin mRNA Conjugated with Lipid Nanoparticles Specifically Targets the Pathogenesis of Type 2 Diabetes
    Rady E. El-Araby, Qisheng Tu, Ying Xie, Tarek Aboushousha, Zhongyu Li, Xiaoyang Xu, Zoe Xiaofang Zhu, Lily Dong, Jake Chen · 2024 · Aging and Disease
  17. Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and Microbiology
    Hoonhee Seo, Sukyung Kim, Samuel Beck, Ho‐Yeon Song · 2024 · Cells
  18. Bioinformatics-based prediction and screening of immunogenic epitopes of Toxoplasma gondii rhoptry proteins 7, 21 and 22 as candidate vaccine target
    Fariha Ayub, Haroon Ahmed, Tehreem Sohail, Khuram Shahzad, Figen Çelik, Xu Wang, Sami Şimşek, Jianping Cao · 2023 · Heliyon
  19. A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses
    Xuechao Han, Zhixiao Gao, Yeping Cheng, Shuoshuo Wu, Jianxing Chen, Weifang Zhang · 2023 · International Journal of Molecular Sciences
  20. Current Understanding of Bacillus Calmette-Guérin-Mediated Trained Immunity and Its Perspectives for Controlling Intracellular Infections
    Ana Carolina V. S. C. de Araujo, Fábio Mambelli, Rodrigo C. O. Sanches, Fabio Vitarelli Marinho, Sergio Costa Oliveira · 2023 · Pathogens
  21. Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: a systematic review
    Takele Adugna, Qingli Niu, Guiquan Guan, Junzheng Du, Jifei Yang, Zhancheng Tian, Hong Yin · 2024 · Frontiers in Immunology
  22. An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA/B α1/2 shedding
    Rui Wang, Jingni Wu, Yifeng Lin, Yufei Xiao, Bin Tang Yang, Sheng Yao, Tianhui Pan, Zhixuan Fu, Shuyu Li, Caihua Wang et al. · 2025 · Cell Reports Medicine
  23. Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
    Etsuro Nanishi, Francesco Borriello, Hyuk‐Soo Seo, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Jing Chen, Joann Diray‐Arce, Kijun Song, Andrew Z. Xu et al. · 2023 · npj Vaccines
  24. Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes
    Myriam Lamrayah, Capucine Phelip, Renaud Rovera, Céline Coiffier, Nora Lazhar, Francesca Bartolomei, Evelyne Colomb, Bernard Verrier, Claire Monge, Sophie Richard · 2023 · Molecules
  25. Just Keep Rolling?—An Encompassing Review towards Accelerated Vaccine Product Life Cycles
    2023
  26. Intranasal mRNA Delivery via Customized RNA-Polyplex Nanoparticles Enhancing Gene Expression through Photochemical Mechanisms
    Hayoon Jeong, Hongjae Kim, Young A Kim, Kyoung Sub Kim, Kun Na · 2023 · ACS Applied Materials & Interfaces
  27. Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis
    Mahya Shabani, Parnian Shobeiri, Shadi Nouri, Zahra Moradi, Robel Assefa Amenu, Mohammad-Mehdi Mehrabi Nejad, Nima Rezaei · 2024 · European journal of medical research
  28. A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine
    Vijayakumar Jawalagatti, Perumalraja Kirthika, Chamith Hewawaduge, Ji-Young Park, Myeon‐Sik Yang, Byungkwan Oh, Mi Young So, Bumseok Kim, John Hwa Lee · 2022 · Frontiers in Immunology
  29. Applications and challenges of biomaterial mediated mRNA delivery
    Huapan Fang, Qian Chen · 2022 · Exploration of Targeted Anti-tumor Therapy
  30. Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants
    Hao Zhou, Ping Leng, Yang Wang, Kaiwen Yang, Chen Li, David M. Ojcius, Pengfei Wang, Shibo Jiang · 2024 · 中国科学通报:英文版
  31. Comprehensive phage display viral antibody profiling using VirScan: potential applications in chronic immune-mediated disease
    Jed Valentiner Shrewsbury, Evangelin Shaloom Vitus, Adam Koziol, Anna Nenarokova, Tine Jess, Rahma Elmahdi · 2024 · Journal of Virology
  32. Nanocarrier vaccines for respiratory infections
    Yinghan Jiang, Luping Lei, Meng Zhao, Yuxin Tian, Yuanyu Huang, Minghui Yang · 2025 · Trends in Molecular Medicine
  33. Recent advances in the biosynthesis of polysaccharide-based antimicrobial glycoconjugate vaccines
    Yuhui Wang, Haodi Liu, Baoying Wang, Gülzire Gheyret, Jingliang Qin, Hanlin Wang, Yuhan Di, Yanling Wang, Juan Wang, Haining Tan · 2025 · Frontiers in Microbiology
  34. Recent advances in the vaccine development for the prophylaxis of SARS Covid-19
    Vipul Kumar, Sahil Kumar, Prabodh Chander Sharma · 2022 · International Immunopharmacology
  35. Next‐Generation Vaccines: Nanovaccines in the Fight against SARS‐CoV‐2 Virus and beyond SARS‐CoV‐2
    Maluta Steven Mufamadi, Mpho Phehello Ngoepe, Ofentse Nobela, Nhlanhla Maluleke, Bafedile Phorah, Banele Methula, Thapelo Maseko, Dipuo Ingrid Masebe, Hazel Tumelo Mufhandu, Lebogang Katata‐Seru · 2023 · BioMed Research International
  36. Recent Global Trends in Vaccinology, Advances and Challenges
    Amjad Islam Aqib, Aftab Ahmad Anjum, Md Atiqul Islam, Asad Murtaza, Aziz Ur Rehman · 2023 · Vaccines
  37. Advances in Zika virus vaccines and therapeutics: A systematic review
    Shiza Malik, Khalid Muhammad, Omar Ahsan, Muhammad Tahir Khan, Ranjit Sah, Yasir Waheed · 2024 · Asian Pacific Journal of Tropical Medicine
  38. Latest advances and prospects in the pathogenesis, animal models, and vaccine research of severe fever with thrombocytopenia syndrome virus
    Chenghao Chen, Jiaxuan Li, Yuhe Zhou, Yuwen Zhang, Renjin Huang, Yanjun Zhang, Jianhua Li, Keda Chen · 2025 · Frontiers in Immunology
  39. Developing Biomaterial‐Based mRNA Delivery System for Lung Disease Treatment
    Qiancheng Gu, Huaqian Xue, Zhiyun Liu, Jiameng Rao, Lingyao Zeng, Chen Zhang, Lanjie Lei, Liyun Shi · 2025 · Advanced Science
  40. Virus-inspired nanozymes for two-dimensional biomimetic penetration and long-acting ferroptosis inhibition in treating dry eye disease
    Qingdong Bao, Qinghua Li, Zhankun Hao, Sihan Zhao, Xiaoxue Liu, Jinyuan Ma, Li Yang, Wenlong Li, Hua Gao · 2025 · Journal of Controlled Release
  41. Lipid Nanoparticle-based mRNA Therapeutics for Infectious Diseases
    Raj Kumar, Nagavendra Kommineni, Keshaw Ram Aadil, Nimeet Desai, Naveen Bunekar, Sagar Salave, Raviteja Bulusu, Deepak Kumar, Lalitkumar K. Vora · 2025 · International Journal of Pharmaceutics
  42. Next-generation vaccines against bacterial pathogens: mRNA and beyond
    Huimin Chen, Ye Gu, Lei Song, Lihui Si · 2025 · Frontiers in Immunology
  43. Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis
    Tomohiro Koga, Masataka Umeda, Nobuya Yoshida, Abhigyan Satyam, Meenakshi Jha, Marc Scherlinger, Rhea Bhargava, Maria Tsokos, Tomohito Sato, Kaori Furukawa et al. · 2022 · Rheumatology
  44. Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
    Chiara Agrati, Concetta Castilletti, Simone Battella, Eleonora Cimini, Giulia Matusali, Andrea Sommella, Alessandra Sacchi, Francesca Colavita, Alessandra Maria Contino, Veronica Bordoni et al. · 2022 · npj Vaccines
  45. Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2
    Ludovica Lombardi, Francesca Maiorca, Ramona Marrapodi, Annamaria Sabetta, Noemi Scafa, Davide Pallucci, Marzia Miglionico, Giulio Francesco Romiti, Bernadette Corica, Silvia Piconese et al. · 2023 · Journal of Thrombosis and Haemostasis
  46. The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2
    Yuan Hu, Lili Liu, Shenghua Zhang, Shaoyu Su, Xiao Liang · 2024 · ACS Omega
  47. Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens
    Ting Wang, Lilan Zheng, Qiujian Zhao, Yazhou Yao, Feng Zhou, Fang Wei, Qiliang Cai · 2023 · Journal of Medical Virology
  48. Antigen Delivery Systems: Past, Present, and Future
    Hyun‐Jeong Ko, Yeon‐Jeong Kim · 2023 · Biomolecules & Therapeutics
  49. How the luxR Gene Affects the Pathogenicity of Pseudomonas plecoglossicida and the Immune Response of Epinephelus coioides
    Lingmin Zhao, Lixing Huang, Yingxue Qin, Dou Yang, Jiaonan Zhang, Jiaolin Zhang, Qingpi Yan · 2023 · Fishes
  50. Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies
    Mario Fragoso-Saavedra, Qiang Liu · 2025 · Virology
  51. Topology‐Oriented Lymph Node Drainage of Dendritic Polymer‐TLR Agonist Conjugates to Enhance Vaccine Immunogenicity
    Long Fang Ren, Bing Wang, Di Miao, Pan Xiang, Zhen Zeng, Zhiqian Li, Xiaoting Chen, Chenjie Xu, Qiyong Gong, Kui Luo et al. · 2025 · Advanced Materials
  52. Advancements in the application and research of baculovirus vector vaccines for respiratory diseases in human
    Yuan, Jinghua, Chen, Jingyu, Zhao, Qingzhi, Xu, Jialu, Li, Xianwei, Zhang, Yijie, Li, Hairun, Chen, Xintong, Zhao, Ling, Zhang, Xiaofen et al. · 2025 · Frontiers in Microbiology
  53. Simultaneous Immunization with Multiple Diverse Immunogens Alters Development of Antigen-Specific Antibody-Mediated Immunity
    Kelsey A. Pilewski, Kevin J. Kramer, Ivelin S. Georgiev · 2021 · Vaccines
  54. Tailoring Design of Nanomaterials and Systems to Individualize Patient Treatments
    Marija Buljan, Peter Wick · 2022 · CHIMIA International Journal for Chemistry
  55. Recombinant vaccines: Current updates and future prospects
    Vivek Kumar, Anuj Verma, Riddhi Singh, Priyanshi Garg, Santosh Kumar Sharma, Himanshu Narayan Singh, Santosh Kumar Mishra, Sanjay Kumar · 2024 · Asian Pacific Journal of Tropical Medicine
  56. Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
    Heedo Park, Mee Sook Park, Jong Hyeon Seok, Jaehwan You, Jeonghun Kim, Jeonghun Kim, Man‐Seong Park · 2022 · The Journal of Microbiology
  57. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)
    Brett A. Leav, Walter L. Straus, P. White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo, Denny Kim, Emily R. Smith, Marc Gurwith, Robert T. Chen · 2022 · Vaccine
  58. Vaccine hesitancy under the lens: Nigeria’s struggle against the worst diphtheria outbreak in decades
    Bashar Haruna Gulumbe, Mohammed Bashar Danlami, Abbas Bazata Yusuf, Aminu Shehu, Obi Chidiebere · 2024 · Therapeutic Advances in Infectious Disease
  59. Recent advances on vaccines against malaria: A review
    Shiza Malik, Yasir Waheed · 2024 · Asian Pacific Journal of Tropical Medicine
  60. Oceanic Breakthroughs: Marine-Derived Innovations in Vaccination, Therapy, and Immune Health
    Chiara Gamberi, Chad L. Leverette, Alexis C Davis, Moayad Ismail, Ilaria Piccialli, Nicola Borbone, Giorgia Oliviero, Caterina Vicidomini, Rosanna Palumbo, Giovanni Nicola Roviello · 2024 · Vaccines
  61. In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment
    Prabhanjan Shridhar Giram, Kazi Md Mahabubur Rahman, Osama Aqel, Youngjae You · 2025 · ACS Biomaterials Science & Engineering
  62. Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
    Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, Siti Nurbaya Oslan · 2024 · Molecular Biotechnology
  63. Inverted HA-EV immunization elicits stalk-specific influenza immunity and cross-protection in mice
    Wandi Zhu, Chunhong Dong, Lai Wei, Joo Kyung Kim, Bao‐Zhong Wang · 2024 · Molecular Therapy
  64. Mechanistic models of humoral kinetics following COVID-19 vaccination
    Daniel Stocks, Amy C Thomas, Adam H.R. Finn, León Danon, Ellen Brooks‐Pollock · 2025 · Journal of The Royal Society Interface
  65. Engineered cell membrane-based nano therapies fight infectious diseases
    Jiaxin Ma, Yijia Xie, Zihao Teng, Lili Jiang, Gang Liu · 2025 · Journal of Controlled Release
  66. An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases
    Parisa Hashemi, Shirin Mahmoodi, Abdolmajid Ghasemian · 2023 · Archives of Microbiology
  67. Platform Technology in Global Vaccine Regulation: Development, Applications, and Regulatory Strategies with Insights from China
    Xiaojing Li, Su Jin, Shuyang Guo, Dan Yang, Wenbo Sai, Xiao Qiu, Xin Zhao, Lan Wang, Tao Wang, Min Li · 2024 · Vaccines
  68. The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children
    Geoffrey A. Weinberg, Annabelle de St. Maurice, Yasmeen Z. Qwaider, Tess Stopczynski, Justin Z. Amarin, Laura S Stewart, John V. Williams, Marian G. Michaels, Leila C. Sahni, Julie A. Boom et al. · 2025 · Journal of the Pediatric Infectious Diseases Society
  69. Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation
    Siyuan Wang, Tao Jiang, Min Jiang, Yang‐Bao Miao · 2025 · Materials Today Bio
  70. Vaccination Update and Specific Concerns for RA
    Mariana Urquiaga, Kevin L. Winthrop, Jeffrey R. Curtis · 2025 · Current Rheumatology Reports
  71. mRNA technology for the prevention and treatment of HIV-1 infection
    Chuang LIU, Alexey V. Yaremenko, Xiaolong Li, Xinru You, Xiaoyu Zhu, Nuo Liu, Wei Chen, Na Kong, Tian Xie, Gaurav D. Gaiha et al. · 2026 · Nature Reviews Bioengineering
  72. Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against Mycobacterium ulcerans
    Tamara Z. Ishwarlall, Victoria T. Adeleke, Leah Maharaj, Moses Okpeku, Adebayo A. Adeniyi, Matthew Adekunle Adeleke · 2023 · Open Biology
  73. Vaccine safety, efficacy, and ethical considerations
    Rashi Shukla, Krupa Vyas, Avinash D. Khadela, Lalitkumar K. Vora, Dharmendra Kumar Khatri · 2024 · Elsevier eBooks
  74. Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review
    Smita Pawar, Prashant Pingale, Atul Garkal, Riyaz Ali M. Osmani, Kavita Rai Gajbhiye, Madhur Kulkarni, Krutika Pardeshi, Tejal A Mehta, Amarjitsing Rajput · 2024 · International Journal of Biological Macromolecules
  75. Exploring the regulatory landscape of non-coding RNAs in aquaculture bacterial pathogens: Piscirickettsia salmonis and Francisella noatunensis
    Víctor Aliaga-Tobar, Raúl Arias‐Carrasco, Adolfo Isla, Javier Santander, Vinicius Maracaja‐Coutinho, Alejandro J. Yáñez · 2024 · Aquaculture
  76. A Simple and Rapid Method of Probiotic Bacterial Ghost Cell Preparation to Deliver Mycobacterium tuberculosis Antigen
    Yesupatham Aarthi, Aravindha Anjana, Glaudia Tejal, Shanmugaraja Meenakshi, S. Ramadevi, R. Princess · 2024 · Molecular Biotechnology
  77. Vaccine delivery: Overcoming the challenges of vaccinating livestock and wildlife
    Freya A. Russell, Dietmar Werner Hutmacher, Tim R. Dargaville, Kenneth W. Beagley · 2024 · Veterinary Vaccine
  78. Current status of recombinant duck enteritis virus vector vaccine research
    Wenfeng Jia, Anping Wang, Zhi Qiang Wu, Xinnuo Lei, Yu‐Ting Cheng, Shanyuan Zhu · 2025 · Frontiers in Veterinary Science
  79. Ad‐E6/7‐HR vaccine improves the prophylactic and therapeutic efficacy in HPV‐associated cancers
    Yu Zhang, Ke Qiu, Jiayuan Ai, Maosen Xu, Binhan Wang, Aqu Alu, Chunjun Ye, Xiya Huang, Yu Long Zhang, Yingqiong Zhou et al. · 2025 · Clinical and Translational Medicine
  80. Recent Developments of RNA Vaccines and Therapeutics: Reagents, Formulations, and Characterization
    Mhd Anas Tomeh, Rachel K. Smith, Allan Watkinson · 2025 · Molecular Pharmaceutics
  81. Codon Usage Evolution in Viruses: Implications for Survival and Pathogenicity
    Shaikh Kaleem, Ujwal Dahal, Shivani Devi, Bhumandeep Kour, Sharanpreet Kour · 2025 · Journal of Molecular Evolution
  82. Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread
    Maireid B. Bull, Carolyn A. Cohen, Nancy Leung, Sophie A. Valkenburg · 2021 · Viruses
  83. Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)
    Jessica Tuan, Heidi J. Zapata, Lydia Barakat, Laurie Andrews, Anousheh Behnegar, Yee Won Kim, Jehanzeb Kayani, Suzana Mutic, Linda Ryall, Barbara Turcotte et al. · 2022 · BMC Infectious Diseases
  84. mRNA Manufacturing and Single‐use Technology – A Perfect Liaison
    António Lima Grilo, Diego R. Schmidhalter · 2022 · Chemie Ingenieur Technik
  85. Vaccines for the prevention of infections in adults with haematological malignancies
    Caroline Hirsch, Paul Jan Bröckelmann, Sibylle C. Mellinghoff, Ana-Mihaela Zorger, Nina Kreuzberger, Ina Monsef, Nicole Skoetz · 2023 · Cochrane Database of Systematic Reviews
  86. mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond
    Satyendra Prakash · 2023 · European Journal of Drug Metabolism and Pharmacokinetics
  87. Enhanced Immune Responses by Virus-Mimetic Polymeric Nanostructures Against Infectious Diseases
    Xinpei Li, Shengqiu Liu, Panchao Yin, Kun Chen · 2022 · Frontiers in Immunology
  88. Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
    Aiquan Chang, Jingyou Yu · 2022 · Viruses
  89. Recent Advances in mRNA Vaccine Development
    Abebe Mengesha Aga, Musin Kelel, Mesfin Tafesse Gemeda · 2023 · Preprints.org
  90. Niosomes: A Comprehensive Review of Their Potential as Drug Carriers
    Shweta Kyadalwar, Shoaeb Mohammad Syed · 2025 · Current Nanomaterials
  91. Current landscape and challenges in adjuvant and antigen delivery systems for vaccine
    Xiaoyi Fu · 2025 · Vaccine X
  92. An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse models
    Zachary R. Stromberg, Elvia E. Silva, Sara C. Johnston, Dylan M. Johnson, Dominique Elaine Hall, Emmanuel Adjei, John A. Altin, Abisola Abisoye-Ogunniyan, Travis R. Gollott, Wei He et al. · 2026 · Frontiers in Immunology
  93. Recent advances in lipid nanoparticles for cancer vaccine delivery: Challenges and future perspectives
    Nurhasni Hasan, Maryam Aftab, Sania Ikram, Apon Zaenal Mustofa, Sriwidodo Sriwidodo, Huda Shalahudin Darusman, Muhammad Nur Amir, Theofilus A. Tockary, Satoshi Uchida · 2026 · International Journal of Pharmaceutics X
  94. Lipid nanoparticle composition directs systemic trafficking and tissue-specific T cell immunity after intramuscular injection
    Christine Y. Wei, Yining Zhu, Xiaoya Lu, Kailei D. Goodier, Di Yu, Xiang Liu, Joseph Choy, Alejandro Téllez Calderón, Yunhe Su, Jingyao Ma et al. · 2026 · Nature Biomedical Engineering
  95. Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities
    Minglong Chen, Yue Xi Zhou, Yànpíng Fù, Qingqing Wang, Chuanbin Wu, Xin Pan, Guilan Quan · 2024 · Expert Opinion on Drug Delivery
  96. Pichia pastoris-Derived β-Glucan Capsules as a Delivery System for DNA Vaccines
    Samara Sousa de Pinho, Maria da Conceição Viana Invenção, Anna Jéssica Duarte Silva, Larissa Silva de Macêdo, Benigno Cristofer Flores Espinoza, Lígia Rosa Sales Leal, Marco Antonio Turiah Machado da Gama, Ingrid Andrêssa de Moura, Micaela Evellin dos Santos Silva, Débora Vitória Santos de Souza et al. · 2024 · Vaccines
  97. Respiratory mucosal vaccines: Applications, delivery strategies and design considerations
    Tingting Shi, Yuqing Ye, Ziyi Fan, Qingliang Yang, Ying Ma, Jesse Zhu · 2025 · Biomedicine & Pharmacotherapy
  98. Whole recombinant yeast-based vaccines: concept, importance, issues, and future scope
    Ravinder Kumar, Vartika Srivastava, Aijaz Ahmad, Santi M. Mandal, Piyush Baindara · 2025 · Critical Reviews in Biotechnology
  99. Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study
    Fuying Gu, Huiying Lin, Zhenqiang Chen, Gareth Ambler, Xinyan Chen, Xiaoling Chen, Pincang Xia, Nan Liu, Houwei Du · 2023 · Vaccines
  100. Trophoblast-Targeted Liposomes for Placenta-Specific Drug Delivery
    Baozhen Zhang, Xiujun Fan, Nihar Ranjan Nayak · 2023 · Methods in molecular biology